Literature DB >> 20876729

Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.

Aleksandar Sekulic1, Su Y Kim, Galen Hostetter, Stephanie Savage, Janine G Einspahr, Anil Prasad, Paul Sagerman, Clara Curiel-Lewandrowski, Robert Krouse, G Timothy Bowden, James Warneke, David S Alberts, Mark R Pittelkow, David DiCaudo, Brian J Nickoloff, Jeffrey M Trent, Michael Bittner.   

Abstract

Cutaneous squamous cell carcinoma (SCC) occurs commonly and can metastasize. Identification of specific molecular aberrations and mechanisms underlying the development and progression of cutaneous SCC may lead to better prognostic and therapeutic approaches and more effective chemoprevention strategies. To identify genetic changes associated with early stages of cutaneous SCC development, we analyzed a series of 40 archived skin tissues ranging from normal skin to invasive SCC. Using high-resolution array-based comparative genomic hybridization, we identified deletions of a region on chromosome 10q harboring the INPP5A gene in 24% of examined SCC tumors. Subsequent validation by immunohistochemistry on an independent sample set of 71 SCC tissues showed reduced INPP5A protein levels in 72% of primary SCC tumors. Decrease in INPP5A protein levels seems to be an early event in SCC development, as it also is observed in 9 of 26 (35%) examined actinic keratoses, the earliest stage in SCC development. Importantly, further reduction of INPP5A levels is seen in a subset of SCC patients as the tumor progresses from primary to metastatic stage. The observed frequency and pattern of loss indicate that INPP5A, a negative regulator of inositol signaling, may play a role in development and progression of cutaneous SCC tumors. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876729      PMCID: PMC2955780          DOI: 10.1158/1940-6207.CAPR-10-0058

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  26 in total

1.  Impaired degradation of Ca(2+)-regulating second messengers in myeloid leukemia cells. Implications for the regulation of leukemia cell proliferation.

Authors:  K E Nye; G A Riley; L W Poulter; E Porfiri; A V Hoffbrand; R G Wickremasinghe
Journal:  Leukemia       Date:  1992-08       Impact factor: 11.528

2.  The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes.

Authors:  T M Connolly; V S Bansal; T E Bross; R F Irvine; P W Majerus
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

3.  Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis.

Authors:  S Popp; S Waltering; H Holtgreve-Grez; A Jauch; C Proby; I M Leigh; P Boukamp
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

4.  Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme.

Authors:  D Fults; C Pedone
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

5.  Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples.

Authors:  Galen Hostetter; Su Young Kim; Stephanie Savage; Gerald C Gooden; Michael Barrett; Jian Zhang; Lalitamba Alla; April Watanabe; Janine Einspahr; Anil Prasad; Brian J Nickoloff; John Carpten; Jeffrey Trent; David Alberts; Michael Bittner
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

6.  Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization.

Authors:  Kevin J Ashton; Stephen R Weinstein; David J Maguire; Lyn R Griffiths
Journal:  Arch Dermatol       Date:  2003-07

7.  Inactivation of calcium ion-regulating inositol polyphosphate second messengers is impaired in subpopulations of human leukemia cells.

Authors:  K Mengubas; S A Jabbar; K E Nye; S Wilkes; A V Hoffbrand; R G Wickremasinghe
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

8.  Skin cancer is among the most costly of all cancers to treat for the Medicare population.

Authors:  Tamara Salam Housman; Steven R Feldman; Phillip M Williford; Alan B Fleischer; Neal D Goldman; Jose M Acostamadiedo; G John Chen
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

9.  Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss.

Authors:  A G Quinn; S Sikkink; J L Rees
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Characterization of a cDNA encoding the 43-kDa membrane-associated inositol-polyphosphate 5-phosphatase.

Authors:  K M Laxminarayan; B K Chan; T Tetaz; P I Bird; C A Mitchell
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  16 in total

1.  A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.

Authors:  Wei Jie Seow; Wen-Chi Pan; Molly L Kile; Lin Tong; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Muhammad Rakibuz-Zaman; Muhammad Kibriya; Habibul Ahsan; Xihong Lin; David C Christiani
Journal:  Cancer       Date:  2015-03-10       Impact factor: 6.860

2.  Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma.

Authors:  A B Patel; A R Mangold; C M Costello; T H Nagel; M L Smith; R E Hayden; A Sekulic
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-02       Impact factor: 6.166

Review 3.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

4.  Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.

Authors:  Connor J Maly; Helen J L Cumsky; Collin M Costello; Jessica E Schmidt; Richard J Butterfield; Nan Zhang; David J DiCaudo; Steven A Nelson; Maxwell L Smith; Shari A Ochoa; Christian L Baum; Thomas H Nagel; Mark R Pittelkow; Aleksandar Sekulic; Aaron R Mangold
Journal:  J Am Acad Dermatol       Date:  2019-08-19       Impact factor: 11.527

5.  Inositol triphosphate signaling triggers lysosome biogenesis via calcium release from endoplasmic reticulum stores.

Authors:  Mouhannad Malek; Volker Haucke
Journal:  Contact (Thousand Oaks)       Date:  2022-05-31

6.  An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.

Authors:  Hassan M Minhas; Matthew F Pescosolido; Matthew Schwede; Justyna Piasecka; John Gaitanis; Umadevi Tantravahi; Eric M Morrow
Journal:  Am J Med Genet A       Date:  2013-03-12       Impact factor: 2.802

7.  Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN.

Authors:  Kaja S Borge; Silje Nord; Peter Van Loo; Ole C Lingjærde; Gjermund Gunnes; Grethe I G Alnæs; Hiroko K Solvang; Torben Lüders; Vessela N Kristensen; Anne-Lise Børresen-Dale; Frode Lingaas
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

8.  Identification of novel genetic alterations in samples of malignant glioma patients.

Authors:  Vedrana Milinkovic; Jasna Bankovic; Miodrag Rakic; Tijana Stankovic; Milica Skender-Gazibara; Sabera Ruzdijic; Nikola Tanic
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 9.  Phosphatidylinositolphosphate phosphatase activities and cancer.

Authors:  Simon A Rudge; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2015-08-24       Impact factor: 5.922

10.  Analysis of genome-wide copy number variations in Chinese indigenous and western pig breeds by 60 K SNP genotyping arrays.

Authors:  Yanan Wang; Zhonglin Tang; Yaqi Sun; Hongyang Wang; Chao Wang; Shaobo Yu; Jing Liu; Yu Zhang; Bin Fan; Kui Li; Bang Liu
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.